Richard P. Slaughter Associates’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-18,901
Closed -$1.26M 154
2024
Q3
$1.26M Sell
18,901
-4,817
-20% -$442K 0.29% 86
2024
Q2
$2.82M Sell
23,718
-730
-3% -$92.4K 0.66% 35
2024
Q1
$2.61M Sell
24,448
-5,555
-19% -$560K 0.63% 41
2023
Q4
$2.98M Buy
30,003
+10,036
+50% +$844K 0.74% 26
2023
Q3
$2.06M Buy
19,967
+3,962
+25% +$442K 0.55% 44
2023
Q2
$1.94M Buy
16,005
+276
+2% +$36.8K 0.56% 50
2023
Q1
$2.42M Sell
15,729
-197
-1% -$32.5K 0.79% 30
2022
Q4
$2.86M Sell
15,926
-23
-0.1% -$3.76K 0.91% 31
2022
Q3
$1.89M Buy
15,949
+1,934
+14% +$293K 0.8% 41
2022
Q2
$2M Buy
14,015
+133
+1% +$19K 0.88% 30
2022
Q1
$2.39M Buy
13,882
+3,192
+30% +$537K 0.9% 35
2021
Q4
$2.71M Buy
10,690
+5,656
+112% +$1.65M 0.96% 32
2021
Q3
$1.94M Sell
5,034
-9,034
-64% -$3.33M 0.77% 43
2021
Q2
$3.31M Buy
+14,068
New +$2.51M 1.28% 19

Other funds holding MRNA